Strategies of medical treatment for metastatic breast cancer (Review).

International journal of oncology

Volumn 19, Issue 4, 2001, Pages 733-739

  Danova, M ^a   Porta, C ^a   Ferrari, S ^a   Riccardi, A ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; MONOCLONAL ANTIBODY;

BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; FEMALE; FORECASTING; HUMAN; METASTASIS; MORTALITY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AROMATASE INHIBITORS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; CROSS-OVER STUDIES; FEMALE; FORECASTING; HUMANS; NEOPLASM METASTASIS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 0035489756     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.19.4.733     Document Type: Review

References (64)